News

Fierce Pharma8h
Fierce Pharma Asia—Pfizer CEO talks bispecific deal; Otsuka's kidney disease win; Novartis-MSN Entresto feud
Pfizer's CEO discussed the extensive due diligence the company has conducted on the 3SBio PD-1xVEGF deal. | Pfizer's CEO ...
BioWorld23h
Biontech’s $1.25B Curevac buyout removes mRNA lawsuit uncertainty
Three years after litigation started over technology used in an mRNA vaccine for COVID-19, Biontech SE is acquiring its ...